Skip to main content

AusPAR: Jakavi

Australian Public Assessment Report
Device/Product Name
Jakavi
Active ingredients
Ruxolitinib phosphate
AusPAR Date
Published
Submission Number
PM-2021-00484-1-6
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site